| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/09/2008 | CN100400070C Externally applied medicine for treating dermatosis and preparation method thereof |
| 07/09/2008 | CN100400052C Medicine for treating oral ulcer, gastric ulcer, burn and scald and traumatic infection and preparing method |
| 07/09/2008 | CN100400049C Medicinal powder for treating beriberi |
| 07/09/2008 | CN100400029C Hair-nourishing, hair-caring and hair-regrowing liquid |
| 07/08/2008 | US7396953 Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396815 Cosmetic or pharmaceutical composition containing peptides |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396682 Genetic engineered protein; joining mammals cells |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396525 Care/makeup compositions comprising a 2-alkylideneaminooxyacetamide compound for stimulating the growth of the hair or eyelashes and/or slowing loss thereof |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2301009C Skin care compositions and use |
| 07/08/2008 | CA2271268C Therapeutic and cosmetic compositions comprising an extract of crude shark liver oil, their use and method for the preparation thereof |
| 07/08/2008 | CA2136848C Pharmaceutically acceptable fixed-dried human blood platelets |
| 07/03/2008 | WO2008079363A2 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008078387A1 Fermented milk for improving and/or treating skin and method for producing the same |
| 07/03/2008 | WO2008078353A1 A novel use of antidepressant compounds and related compositions |
| 07/03/2008 | WO2008078099A1 Lxr- antagonists for the prevention, reduction or inhibition of scarring |
| 07/03/2008 | WO2008078074A1 Promotion of wound contraction with a compound that promotes oestrogenic activity |
| 07/03/2008 | WO2008078073A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | WO2008078071A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | WO2008077542A1 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases |
| 07/03/2008 | WO2008077541A1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases |
| 07/03/2008 | WO2008077201A1 Naphthalan oil-based composition |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | WO2008049401A3 Nail varnish for cosmetic and medical applications |
| 07/03/2008 | WO2008047061A3 Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition |
| 07/03/2008 | WO2007136653A3 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 07/03/2008 | WO2007101357A3 Hair growth agent for the treatment of human keratin fibers, and method for the production thereof |
| 07/03/2008 | WO2006134494A3 Anti-connexin compounds and therapeutic uses thereof |
| 07/03/2008 | US20080161782 Micropore delivery of active substances |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161426 p53 Inhibitors and Therapeutic Use of the Same |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161384 Topical skin application; immediate relief |
| 07/03/2008 | US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161273 Method of Using Adapalene in Acne Maintenance Therapy |
| 07/03/2008 | US20080161272 Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161233 Sustained Release Formulation of a Peptide |
| 07/03/2008 | US20080160617 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same, and use of the same |
| 07/03/2008 | US20080160612 Using weak acid as biocide in disinfection of mammalian tissues |
| 07/03/2008 | US20080160118 Applying defatted extract or an extract of defatted seeds; soothing, relieving the skin, the scalp, and/or the hair; UV radiation; environmental irritations, pollutions, dandruff, dry skin, inflammation, rosacea |
| 07/03/2008 | US20080160114 Composition of Skin External Application Containing Rose Extract and Epigallocatechin Gallate(Egcg) |
| 07/03/2008 | US20080160113 Herbal extract of Wrightia tinctoria, an herbal extract of Cocos nucifera and excipients; ointment, oil, soap and shampoo; inflammatory skin disorders, psoriasis |
| 07/03/2008 | US20080160109 Compositions and methods of their use for improving the condition and appearance of skin |
| 07/03/2008 | US20080160088 Used for preventing and/or reducing the embrittlement of the skin and/or semi-mucous membranes and/or for protecting the skin and/or semi-mucous membranes against water loss and/or external attack; comprises calcium salt preferably calcium pantetheine sulfonate |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160064 non-gaseous CO dissolved in a reservoir material; on soft tissue implants and/or medical devices; breast implants |
| 07/03/2008 | US20080160043 High yield production using adherence of mushroom mycelia and removal of by products during culturing; relieving skin dryness, pruritus and pain |
| 07/03/2008 | US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders |
| 07/03/2008 | US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080159999 Cell differentiation; transfection; gene therapy; tissue engineering; Alzheimer's disease, Parkinson's disease, arthritis |
| 07/03/2008 | US20080159979 Treatment of wounds using il-17b |
| 07/03/2008 | US20080159978 Using bioactive compounds to induce or accelerate healing of damaged skin |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/03/2008 | US20080159969 Pharmaceutical Or Cosmetic Composition Comprising Mequinol And At Least One Depigmenting Agent |
| 07/03/2008 | DE102007001019A1 Cosmetic compositions useful for care and conditioning of keratinic fibers, especially hair, comprise a mineral powder and a cationic, amphoteric or zwitterionic polymer |
| 07/03/2008 | DE102006062566A1 Cosmetic or dermatological topical composition, useful to treat the blemished skin and/or acne, comprises an alpha-monoalkyl glycerin ether and an active agent comprising octanediol or hexanediol in a carrier |
| 07/03/2008 | DE102006062501A1 Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften Cosmetic and dermatological oil-in-water emulsions with self-preserving properties |
| 07/03/2008 | DE102006062433A1 Deodorant or antiperspirant composition comprises a deodorant or antiperspirant agent and taurine in a carrier |
| 07/03/2008 | CA2674553A1 Promotion of wound contraction with a compound that promotes oestrogenic activity |
| 07/03/2008 | CA2673714A1 Fermented milk for skin improvement and/or treatment and process for producing the same |
| 07/03/2008 | CA2673712A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673638A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673486A1 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938819A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938818A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938817A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 07/02/2008 | EP1938809A1 Adhesive skin patch |
| 07/02/2008 | EP1938785A2 Cosmetic and dermatological oil-in-water emulsions with self-preserving attributes |
| 07/02/2008 | EP1937619A1 Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
| 07/02/2008 | EP1937366A1 Synergistic mixtures of bisabolol and ginger extract |
| 07/02/2008 | EP1937326A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 07/02/2008 | EP1937281A2 Modulation of trpv expression levels |
| 07/02/2008 | EP1937254A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |